NCT04148937 2024-04-05A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed52 enrolled 21 charts
NCT02762981 2022-12-06Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid TumorsCorcept TherapeuticsPhase 1/2 Completed85 enrolled 24 charts
NCT01631552 2021-08-12Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerGilead SciencesPhase 1/2 Completed515 enrolled 28 charts 2 FDA
NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts